Published in Women's Health Weekly, August 3rd, 2000
The data were presented at the World Federation of Hemophilia's Annual Meeting, "Hemophilia 2000 Congress," held in King of Prussia, Pennsylvania, during July 2000. Humate-P is the only factor concentrate approved in the United States for the treatment of vWD, the most common inherited bleeding disorder estimated to effect more than 2.5 million people in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.